[
Methods Mol Biol,
2015]
Optogenetics was introduced as a new technology in the neurosciences about a decade ago (Zemelman et al., Neuron 33:15-22, 2002; Boyden et al., Nat Neurosci 8:1263-1268, 2005; Nagel et al., Curr Biol 15:2279-2284, 2005; Zemelman et al., Proc Natl Acad Sci USA 100:1352-1357, 2003). It combines optics, genetics, and bioengineering to render neurons sensitive to light, in order to achieve a precise, exogenous, and noninvasive control of membrane potential, intracellular signaling, network activity, or behavior (Rein and Deussing, Mol Genet Genomics 287:95-109, 2012; Yizhar et al., Neuron 71:9-34, 2011). As C. elegans is transparent, genetically amenable, has a small nervous system mapped with synapse resolution, and exhibits a rich behavioral repertoire, it is especially open to optogenetic methods (White et al., Philos Trans R Soc Lond B Biol Sci 314:1-340, 1986; De Bono et al., Optogenetic actuation, inhibition, modulation and readout for neuronal networks generating behavior in the nematode Caenorhabditis elegans, In: Hegemann P, Sigrist SJ (eds) Optogenetics, De Gruyter, Berlin, 2013; Husson et al., Biol Cell 105:235-250, 2013; Xu and Kim, Nat Rev Genet 12:793-801, 2011). Optogenetics, by now an "exploding" field, comprises a repertoire of different tools ranging from transgenically expressed photo-sensor proteins (Boyden et al., Nat Neurosci 8:1263-1268, 2005; Nagel et al., Curr Biol 15:2279-2284, 2005) or cascades (Zemelman et al., Neuron 33:15-22, 2002) to chemical biology approaches, using photochromic ligands of endogenous channels (Szobota et al., Neuron 54:535-545, 2007). Here, we will focus only on optogenetics utilizing microbial rhodopsins, as these are most easily and most widely applied in C. elegans. For other optogenetic tools, for example the photoactivated adenylyl cyclases (PACs, that drive neuronal activity by increasing synaptic vesicle priming, thus exaggerating rather than overriding the intrinsic activity of a neuron, as occurs with rhodopsins), we refer to other literature (Weissenberger et al., J Neurochem 116:616-625, 2011; Steuer Costa et al., Photoactivated adenylyl cyclases as optogenetic modulators of neuronal activity, In: Cambridge S (ed) Photswitching proteins, Springer, New York, 2014). In this chapter, we will give an overview of rhodopsin-based optogenetic tools, their properties and function, as well as their combination with genetically encoded indicators of neuronal activity. As there is not "the" single optogenetic experiment we could describe here, we will focus more on general concepts and "dos and don'ts" when designing an optogenetic experiment. We will also give some guidelines on which hardware to use, and then describe a typical example of an optogenetic experiment to analyze the function of the neuromuscular junction, and another application, which is Ca(2+) imaging in body wall muscle, with upstream neuronal excitation using optogenetic stimulation. To obtain a more general overview of optogenetics and optogenetic tools, we refer the reader to an extensive collection of review articles, and in particular to volume 1148 of this book series, "Photoswitching Proteins."
[
European Worm Meeting,
2000]
More than 50 genes involved in vulva development have been characterized in the rhabditid C. elegans. The extensive characterization of this model system provides a framework for studying the genetic basis of evolutionary modifications. Cell fate specification during vulva formation differs significantly between C. elegansand the diplogasterid nematode Pristionchus pacificus. Cell ablation experiments in P. pacificus demonstrate the existence of several novel cell-cell interactions (Sigrist and Sommer, 1999; Sommer and Sternberg, 1996). To understand the molecular mechanisms underlying vulval pattern formation in P. pacificus, we performed several TMP/UV and EMS mutagenesis screens. The mutants isolated in these screens fall into two categories: I) "generation-vulvaless" mutants do not generate Pn.p cells; II) "induction-vulvaless" mutants generate Pn.p cells, but these fail to differentiate. We have isolated and characterized a new class of induction vulvaless mutants, in which P6.p differentiates as a normal 1 cell, but P5.p and P7.p adopt a non-vulval fate (3). In wild type P. pacificus, as in C. elegans, P6.p adopts the 1 fate, whereas P5.p and P7.p generate the 2 lineage. Four mutants,
tu114(TMP/UV),
tu132(EMS),
tu48(EMS) and
tu51 (EMS), display this defect to different extents. Complementation test among these mutants are in progress. We are using a PCR-based genomic substraction strategy (RDA) to identify the deletion associated with the
tu114 mutant. The identification of the genes involved in the induction of the vulva in P. pacificus may help us understand how molecular mechanisms change during evolution. Sigrist, C. B., and Sommer, R. J. (1999). Vulva formation in Pristionchus pacificus relies on continuous gonadal induction. Dev Genes Evol 209, 451-9. Sommer, R. J., and Sternberg, P. W. (1996). Apoptosis and change of competence limit the size of the vulva equivalence group in Pristionchus pacificus: a genetic analysis. Curr Biol 6, 52-9.
[
European Worm Meeting,
2000]
More than 50 genes involved in vulva development have been characterized in the rhabditid C. elegans. The extensive characterization of this model system provides a framework for studying the genetic basis of evolutionary modifications. Cell fate specification during vulva formation differs significantly between C. elegansand the diplogasterid nematode Pristionchus pacificus. Cell ablation experiments in P. pacificus demonstrate the existence of several novel cell-cell interactions (Sigrist and Sommer, 1999; Sommer and Sternberg, 1996). To understand the molecular mechanisms underlying vulval pattern formation in P. pacificus, we performed several TMP/UV and EMS mutagenesis screens. The mutants isolated in these screens fall into two categories: I) "generation-vulvaless" mutants do not generate Pn.p cells; II) "induction-vulvaless" mutants generate Pn.p cells, but these fail to differentiate. We have isolated and characterized a new class of induction vulvaless mutants, in which P6.p differentiates as a normal 1 cell, but P5.p and P7.p adopt a non-vulval fate (3). In wild type P. pacificus, as in C. elegans, P6.p adopts the 1 fate, whereas P5.p and P7.p generate the 2 lineage. Four mutants,
tu114 (TMP/UV),
tu132 (EMS),
tu48 (EMS) and
tu51 (EMS), display this defect to different extents. Complementation test among these mutants are in progress. We are using a PCR-based genomic substraction strategy (RDA) to identify the deletion associated with the
tu114 mutant. The identification of the genes involved in the induction of the vulva in P. pacificus may help us understand how molecular mechanisms change during evolution. Sigrist, C. B., and Sommer, R. J. (1999). Vulva formation in Pristionchus pacificus relies on continuous gonadal induction. Dev Genes Evol 209, 451-9. Sommer, R. J., and Sternberg, P. W. (1996). Apoptosis and change of competence limit the size of the vulva equivalence group in Pristionchus pacificus: a genetic analysis. Curr Biol 6, 52-9.
Madeo F, Markaki M, Michael E, Carmona-Gutierrez D, Alavian-Ghavanini A, Habernig L, Tavernarakis N, Broeskamp F, Eisenberg T, Buttner S, Kroemer G, Sommer C, Sigrist SJ
[
Cell Cycle,
2014]
As our society ages, neurodegenerative disorders like Parkinsons disease (PD) are increasing in pandemic proportions. While mechanistic understanding of PD is advancing, a treatment with well tolerable drugs is still elusive. Here, we show that administration of the naturally occurring polyamine spermidine, which declines continuously during aging in various species, alleviates a series of PD-related degenerative processes in the fruit fly Drosophila melanogaster and the nematode Caenorhabditis elegans, two established model systems for PD pathology. In the fruit fly, simple feeding with spermidine inhibited loss of climbing activity and early organismal death upon heterologous expression of human -synuclein, which is thought to be the principal toxic trigger of PD. In this line, administration of spermidine rescued -synuclein-induced loss of dopaminergic neurons, a hallmark of PD, in nematodes. Alleviation of PD-related neurodegeneration by spermidine was accompanied by induction of autophagy, suggesting that this cytoprotective process may be responsible for the beneficial effects of spermidine administration.
[
International Worm Meeting,
2013]
In order to ameliorate the deleterious consequences of old age, the biology of human ageing must be understood. The study of human progeroid disorders which recapitulate many of the features of normal ageing have helped to contribute to our understanding of normal human ageing. Werner syndrome is a canonical progeroid disorder, caused by mutation of the WRN gene. WRN encodes both RecQ helicase and exonuclease activities, and is known to participate in DNA replication, repair, recombination and telomere maintenance. In addition, although many interacting partners have been identified, the exact molecular functions of the WRN gene remain largely unknown. In order to dissect the roles of WRN helicase in ageing, we use mutants of the WRN homologue and interacting partners in the nematode worm, C. elegans.
Reduction of function by RNA interference of the C. elegans WRN homologue
wrn-1 leads to ageing phenotypes and shortened lifespan 1. We have shown that mutation of
wrn-1 leads to genomic instability: interestingly, this phenotype is enhanced in a mutant
cep-1 background (the C. elegans
p53 homologue). Notably, lifespan also shows significant modulation, while brood size remains unchanged from that of either single mutant.
Therefore we suggest that
cep-1 status has a significant effect upon the role of
wrn-1 helicase in longevity and germline maintenance in worms.
References 1.Lee, SJ; Yook, JS; Han, SM; Koo, HS. A Werner syndrome protein homolog affects C. elegans development, growth rate, life span and sensitivity to DNA damage by acting at a DNA damage checkpoint. Development, 2004. 131(11): p. 2565-2575.
[
International Worm Meeting,
2011]
A major goal of aging research is to understand the underlying relationship between nutritional intake, metabolism, and healthy aging. Low-glycemic index diets have been shown to reduce risk of age-related metabolic diseases such as diabetes and cardiovascular disease, and reduced caloric intake via dietary restriction increases healthspan across species. One potential approach for supporting healthy aging is via interventions that engage healthspan-promoting metabolism. In Caenorhabditis elegans, adding excess glucose to the growth medium shortens lifespan [1, 2], while inhibiting the glycolytic enzyme hexokinase with the glucose analog 2-deoxyglucose increases lifespan [1]. We have shown that disrupting genes encoding two other glycolytic enzymes that catalyze unidirectional, irreversible reactions lengthens C. elegans median lifespan, induces large gains in youthful locomotory ability, and triggers a fluorescent biomarker that distinguishes a healthy metabolic state. Conversely, disrupting counterpart gluconeogenic genes decreases nematode healthspan. In investigating potential longevity-related pathways that might impinge upon glucose metabolism, we found that disrupting glycolytic genes increases healthspan through the FOXO transcription factor DAF-16, which is also required for the increased lifespan seen with lowered levels of insulin signaling, and which is downregulated by increased glucose availability [2]. Strikingly, we also found that gluconeogenic activity is absolutely and specifically required for increased healthspan under dietary restriction. These results provide evidence for an intriguing new paradigm: breakdown of glucose via glycolysis negatively impacts healthy aging through insulin signaling and DAF-16, while dietary restriction engages the reciprocal gluconeogenic pathway to promote healthspan. Our observations support that healthspan might be optimized via dietary, pharmacological, or genetic interventions that increase gluconeogenic activity or decrease glycolysis. 1. Schulz TJ, Zarse K, Voigt A, Urban N, Birringer M, et al. (2007). Cell Metab 6: 280-293. 2. Lee SJ, Murhpy CT, Kenyon C (2009). Cell Metab 10: 379-391.